Stay updated on Pembrolizumab in MSI Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The history now shows the latest revision as v3.6.5, replacing the previous v3.6.4.
    Difference
    0.1%
    Check dated 2026-08-10T12:50:48.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    A new revision entry v3.6.4 was added to the study history, replacing the previous revision v3.6.3. This updates the history record without modifying study data or results.
    Difference
    0.1%
    Check dated 2026-07-27T06:38:41.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The record history gains a new revision entry v3.6.3, and the prior revision v3.6.2 is removed from the visible changes.
    Difference
    0.1%
    Check dated 2026-07-05T14:30:20.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The history now includes a new revision entry v3.6.2, indicating a subsequent update to the record. The previous revision v3.6.0 is no longer listed in the history.
    Difference
    0.1%
    Check dated 2026-06-28T08:39:13.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The study record now states 'No longer looking for participants', indicating recruitment is closed for this trial. The revision line shows 'Revision: v3.6.0' replacing the previous 'Revision: v3.5.5', signaling an updated version of the study record.
    Difference
    0.3%
    Check dated 2026-06-14T00:23:41.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    A new site revision entry (v3.5.5) is added to the record history, replacing the previous revision (v3.5.4) and signaling an updated deployment of the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-06-06T19:40:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.